GRCE

Grace Therapeutics, Inc. Common Stock
GRCE

Overview Fund Activity

26 hedge funds and large institutions have $1.88M invested in Grace Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$979K
2
Citadel Advisors
Citadel Advisors
Florida
$62K
3
Squarepoint
Squarepoint
New York
$53K
4
Millennium Management
Millennium Management
New York
$21K
5
UBS Group
UBS Group
Switzerland
$15K

Top Sellers

1
Bank of Montreal
Bank of Montreal
Ontario, Canada
$6K
2
Morgan Stanley
Morgan Stanley
New York
$101K
3
VF
Virtu Financial
New York
$411K
4
Jane Street
Jane Street
New York
$0
5
Two Sigma Advisers
Two Sigma Advisers
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SFA
26
Sequoia Financial Advisors
Ohio
– -$6K -208 Closed
PCIA
27
Prime Capital Investment Advisors
Kansas
– -$1K -42 Closed
1
2